Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Genomics|November 11, 2024
Targeting splicing for hematological malignancies therapyMonika Szelest, Krzysztof Giannopoulos
Molecular Medicine (Cambridge, Mass.)|May 17, 2024
Biological relevance of alternative splicing in hematologic malignanciesMonika Szelest, Krzysztof Giannopoulos
International Journal of Molecular Sciences|January 27, 2021
A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological ProcessesMonika Szelest, Katarzyna Walczak, Tomasz Plech
BMC Medical Genomics|March 11, 2021
Three case reports of patients indicating the diversity of molecular and clinical features of 16p11.2 microdeletion anomalyMonika Szelest, Martyna Stefaniak, Gabriela Ręka, et al.
International Journal of Molecular Sciences|October 29, 2020
Effect of Tryptophan-Derived AhR Ligands, Kynurenine, Kynurenic Acid and FICZ, on Proliferation, Cell Cycle Regulation and Cell Death of Melanoma Cells-In Vitro StudiesKatarzyna Walczak, Ewa Langner, Anna Makuch-Kocka, et al.
Cancer Genetics|November 13, 2024
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myelomaMarta Morawska, Michał Kiełbus, Magdalena Paziewska, et al.
Plos One|October 25, 2022
The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemiaMonika Szelest, Marta Masternak, Małgorzata Zając, et al.
Oncology Letters|September 27, 2024
Increased abundance of <i>Firmicutes</i> and depletion of <i>Bacteroidota</i> predicts poor outcome in chronic lymphocytic leukemiaMagdalena Paziewska, Monika Szelest, Michał Kiełbus, et al.
BMC Cancer|June 25, 2026
Integrated analysis of IGHV rearrangements and cytogenetic abnormalities in a large chronic lymphocytic leukemia cohort (CLL-POL1)Paulina Własiuk, Monika Szelest, Magdalena Paziewska, et al.
The Journal of Molecular Diagnostics : JMD|September 25, 2025
TAG-CLL, a Novel Tagmentation-Based Approach to Somatic Hypermutation Testing of IGHV Reveals the Weak Points of Both Sanger and Next-Generation Sequencing MethodsMarzena Wojtaszewska, Monika Szelest, Marta Szarawarska, et al.
Pageof 1